Beyond COVID-19: Can mRNA Treat Diseases, Too?
Secondly, the FDA has yet to greenlight any of these treatments. What’s more, some early trials of mRNA therapies have suffered major stumbling blocks on the road to market approval. In January, CureVac reported disappointing results in a clinical trial of its new mRNA-based drug for prostate cancer. The company’s CV9014 drug did … Read more